RE: RE: Gary Economo from Proactive Investors Yes, a good summation by Gary. Unfortunately the market is not viewing this with open arms, down to .94 to start the morning off. It is so strange to me that the market views every NR with such negativity and it seems like NGC can do no wrong, up 8% yesterday on no news. It is frustrating to watch, yet at the same time it has given me time to accumulate a silly number of shares, so I am quite thrilled for what the future will hold here.
It seems a lot of small minded sentiment when you release the news yesterday and it sells off. Investors are missing the huge take-away from this NR....by how I read it, FMS and Grafoid have the patent pending process in their hands now! This should have been the title of the NR if they wanted to turn some heads. At that point, the money and the scheme of the financial arrangement would be secondary. Obviously others had issue with the structure of the deal, some mentioned it left a slightly bad taste in their mouth, I would tend to agree in general. That being said, this deal may very well have reverberations through the entire industry, placing Focus ahead as the first mover with the best prospects, best property, and now best product with the lowest cost of production. Oh well, invest in NGC if 3% grade at best if your thing, best of luck to both companies, certainly need for both and more.